CancerLivER: Biomarker Card

Biomarker Card: Comprehensive information about a biomarker


Biomarker ID 2538
Detailed information
CancerLivER ID2538
Biomarker ILF2, BMI1, TAF9, RFX5, SSRP1, ZNF146, SREBF2, MAFG, CHD4, NR4A1, ESR1, ZNF238, FOSB, ID1, FOS, H2AFY, SNRPB, RPS7, MRPS14, HNRPU, SNRPD2, NCL, RPS10, RPL6, SFPQ, DIM1, MARS, SFRS9, RBM3, U2AF65, SFRS1, SNRPE, SF3B4, RDBP, SNRPF, RRM1, RPL38, HNRPH1, U5-116KD, RPLP1, OXA1L, ADPRT, PRKDC, SMC4L1, H2A
Biomarker Name/Symbol (given in Publication)ILF2, BMI1, TAF9, RFX5, SSRP1, ZNF146, SREBF2, MAFG, CHD4, NR4A1, ESR1, ZNF238, FOSB, ID1, FOS, H2AFY, SNRPB, RPS7, MRPS14, HNRPU, SNRPD2, NCL, RPS10, RPL6, SFPQ, DIM1, MARS, SFRS9, RBM3, U2AF65, SFRS1, SNRPE, SF3B4, RDBP, SNRPF, RRM1, RPL38, HNRPH1, U5-116KD, RPLP1, OXA1L, ADPRT, PRKDC, SMC4L1, H2AV, FEN1, MCM2, HAT1, RAD50, CBX1, CSPG6, FUS, UNG2, GPC3, CDKN2A, MDK, NTRK1, CCNE2, HDGF, TP53BP2, CDC23, GRN, GHR, IGFBP3, CYR61, HGF, DAP3, PDCD5, PPIA, TMPO, PPIB, CD5L, SCYA14, SDF1, IGHG3, C7, IGJ, IGKC, LBR, ITGB1, LAMR1, CAPZA2, ICAP-1A, DNCH1, ARPC1A, DPT, MMP15, ARHE, CAP2, CSTB, ARMET, EFNA1, PPP2R5A, RAN, CALM2, LASP1, SHC1, RGS5, HAX1, GABRE, ARFGEF2, MAPK6, GNB2L1, ERBB3, DSCR1, CRHBP, STK39, UBD, PSMB4, SSA2, USP14, PSMA1, EIF3S9, SMT3H1, UBE2D2, PSMD11, PSMB3, PSMD4, CCT5, CCT3, HSPA5, CCT4, HSPA4, CCT7, HSPA8, CCT6A, ANXA2, PDZK1, SYPL, TIMM17A, XPO1, HMGN4, NUCB2, UGTREL1, PEA15, CLTA, ATP6IP1, SSR2, AP3S1, VDAC2, VPS45A, VCP, SACM2L, KPNB1, SLC21A3, SLC22A1, GNPAT, NME2, NME1, UQCRH, TALDO1, P5CR2, GFPT1, DPM1, ACLY, B4GALT3, GCN1L1, DPAGT1, ACAA1, ALDH8A1, SRD5A2, NAT2, GSTZ1, ADH1B, CYP2C8, CYP2E, ECT2, DKFZP564B167, KIAA0016, DXS1357E, KIAA0475, C20orf24, FLJ10326, KIAA0117, DEK, PODXL, DSS1, PRO1855, KIAA0470, MYLE, MAGED2, FLJ12806, YWHAB, LOC51235, KIAA0592, KIAA0205, C1orf9, KIAA0788, MGC19556, KIAA0731, C7orf14, D123, C5orf8, AD24, WHIP, BC-2, DKFZP547E101, FLJ22251, KIAA0187, MPV17, MAWBP, FLJ12666, RNAHP
BiomoleculeRNAs
SubjectHuman
Degree of ValidityBiomarker for HCC diagnosis and validated on independent dataset
Experimental ConditionHCC v/s non-tumor
Cancer typeHepatocellular carcinoma
RegulationDifferentially Expressed in HCC Tumors than non-tumor (with fold change of 1.5)
Level of significance p < 0.01
SourceTissue
PMID15057898
Type of BiomarkerDiagnostic
Pathway
CohortTraining dataset: primary HCC tumor specimens and the corresponding nontumor liver tissue specimens from 37 patients; Validation dataset: 58 liver clinical biopsy specimens from 29 patients.
SensitivityNA
SpecificityNA
Accuracy93%
AUCNA
DiseaseHCC v/s non-tumor
Year of Publication2002
Clinical trialNO
Clinical trial (NCT Number)NA

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top